Citations
7 publicationsPublications from researchers using this productDescription
Sulforaphane is an isothiocyanate that is present naturally in cruciferous vegetables with anti-oxidant, anti-inflammatory, and anti-bacterial effects[1]. Sulforaphane can function by blocking initiation via inhibiting Phase 1 enzymes that convert procarcinogens to proximate or ultimate carcinogens, and by inducing Phase 2 enzymes that detoxify carcinogens and facilitate their excretion from the body[2]. Sulforaphane has been widely used to inhibit the proliferation of various cancer cells and to improve oxidative stress[3].
In vitro, Sulforaphane treatment for 24 hours significantly inhibited the viability of OECM-1 cells, with an IC50 value of 5.7μM[4]. Treatment with 10μM Sulforaphane for 48 hours significantly induced apoptosis in MDAH-2774 cells, accompanied by an increase in the expression of pro-apoptotic protein BAK, while the expression of anti-apoptotic protein Bcl-2 decreased[5]. Treatment with 20μM Sulforaphane for 24 hours significantly reduced the expression of EGFR and EGFR signaling in A549 cells, and decreased cell viability[6].
In vivo, Sulforaphane treatment via oral administration at a dose of 20mg/kg/day for 2 weeks alleviated dextran sulfate sodium (DSS)-induced ulcerative colitis and reversed gut dysbiosis in mice[7]. Oral administration of Sulforaphane at a dose of 1g/kg/day for 6 weeks alleviated high-fat diet-induced visceral fat accumulation, adipocyte hypertrophy, and hepatic steatosis in mice[8].
References:
[1] Fimognari C, Hrelia P. Sulforaphane as a promising molecule for fighting cancer[J]. Mutation Research/Reviews in Mutation Research, 2007, 635(2-3): 90-104.
[2] Clarke J D, Dashwood R H, Ho E. Multi-targeted prevention of cancer by sulforaphane[J]. Cancer letters, 2008, 269(2): 291-304.
[3] Guerrero-Beltrán C E, Calderón-Oliver M, Pedraza-Chaverri J, et al. Protective effect of sulforaphane against oxidative stress: recent advances[J]. Experimental and Toxicologic Pathology, 2012, 64(5): 503-508.
[4] Adtani P N, Al-Bayati S A A F, Elsayed W S. Sulforaphane from brassica oleracea induces apoptosis in oral squamous carcinoma cells via p53 activation and mitochondrial membrane potential dysfunction[J]. Pharmaceuticals, 2025, 18(3): 393.
[5] Bryant C S, Kumar S, Chamala S, et al. Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells[J]. Molecular cancer, 2010, 9(1): 47.
[6] Chen C Y, Yu Z Y, Chuang Y S, et al. Sulforaphane attenuates EGFR signaling in NSCLC cells[J]. Journal of biomedical science, 2015, 22(1): 38.
[7] Zhang Y, Tan L, Li C, et al. Sulforaphane alter the microbiota and mitigate colitis severity on mice ulcerative colitis induced by DSS[J]. Amb Express, 2020, 10(1): 119.
[8] Choi K M, Lee Y S, Kim W, et al. Sulforaphane attenuates obesity by inhibiting adipogenesis and activating the AMPK pathway in obese mice[J]. The Journal of nutritional biochemistry, 2014, 25(2): 201-207.
Protocol
| Cell experiment [1]: | |
Cell lines | OECM-1 cells |
Preparation Method | OECM-1 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM)/F-12 enriched with 10% fetal bovine serum (FBS) and 1% antimycotic-antibiotic at 37°C in 5% CO2/atmosphere. Cells were seeded at a density of 2×104 cells/ml in the 96-well plates and allowed to adhere in a 5% CO2 incubator at 37°C for 24h. The cells were treated with different concentrations of Sulforaphane (0, 3.125, 6.25, 12.5, 50, and 100μM) for 24h. The cell viability was evaluated. |
Reaction Conditions | 0, 3.125, 6.25, 12.5, 50, and 100μM; 24h |
Applications | Sulforaphane treatment significantly inhibited cell viability of OECM-1 cells in a dose-dependent manner. |
| Animal experiment [2]: | |
Animal models | Male C57BL/6N mice |
Preparation Method | Male C57BL/6N mice (4-week-old) were housed in a room with controlled temperature (21-23°C), humidity (55%-60%) and lighting (12h light/dark cycle) and were supplied with water ad libitum. After acclimation for 1 week, mice were randomly divided into three groups (n=10/group) and fed a normal diet (ND; 4.3% fat; 43g fat/kg diet), high-fat diet (24% fat; 240g fat/kg diet) or high-fat diet plus 0.1% Sulforaphane (1g/kg) for 6 weeks. At the end of the experimental period, mice were anesthetized, blood was collected for analysis. |
Dosage form | 1g/kg/day; 6 weeks; p.o. |
Applications | Sulforaphane treatment significantly reduced serum total cholesterol and leptin, and liver triglyceride levels in mice with high-fat diet. |
References: | |
Product Documents
Chemical Properties
Use stock solutions within 6 months when stored at -80°C or within 1 month when stored at -20°C.
To improve solubility, warm the tube to 37°C and sonicate it for an appropriate period.
CalculatorsMolarity / Dilution / Molecular Weight / Unit Conversion / In Vivo Formulation / Solubility
Reviews
Review for Sulforaphane
- 5 Star100%
- 4 Star0%
- 3 Star0%
- 2 Star0%
- 1 Star0%
